common.study.topics.clinical

Defining Recurrent Disease with Axuminâ„¢

common.study.values.description

Defining Recurrent Disease With Axuminâ„¢

This project seeks to use advanced imaging (specifically, positron emission tomography/computed tomography [PET/CT]) to detect, locate, and characterize recurrent disease in the setting of patients with prostate cancer.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Casodex, Axumin

Patients will receive hormone therapy if Axumin positive area appears.

Radiation - Salvage Radiation, Axumin

Patients will receive salvage radiation therapy if Axumin positive area appears.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Diagnosing and Monitoring Recurrent Disease in Prostate Cancer Patients Using a Positron Emission Tomography Radiotracer (Axuminâ„¢)

common.study.values.clinical-trial-id

NCT03996993

participant.views.study.view.id

dwp68e